NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which reference is specific to biosimilar therapeutic equivalents?

  1. FDA's Orange book: therapeutic equivalents

  2. FDA's Purple book: biosimilar equivalents

  3. ASHP

  4. AHFS CDI

The correct answer is: FDA's Purple book: biosimilar equivalents

The Purple book from the FDA specifically lists approved biosimilar drugs and their respective reference products. This makes option B the most accurate choice for identifying biosimilar therapeutic equivalents. Option A, the Orange book, only lists therapeutic equivalents but not specifically for biosimilars. Option C, ASHP, is an organization for pharmacists and does not provide information on biosimilar equivalents. Option D, AHFS CDI, is a drug information database but does not list biosimilar equivalents specifically.